We interrogated a random draw of 18,965 genes from 25 diseases including neurological and neuropsychiatric disorders that today often receive the Autism label. We also included non-neurological diseases in the set, and asked if using the genes' expression on 54 tissues defined by the GETex project, we could stratify Autism as we know it today, made up of all these neuropsychiatric and neurological disorders. We found a self-emerging stratification that informs us of new ways to recommend treatments in Autism by leveraging existing therapies that are not defined by "inappropriate behaviors" but rather address physiological issues.

The question is whether we are going to continue following this archaic Autism diagnosis-to-treatment pipeline and circularly informing science by criteria that feeds the Autism Industrial Complex and makes each one of these families into a commodity, or move away from all of it and rely on medical and physiological issues. The preprint is in the bioRxvi and I welcome comments on the results of this interrogation and the proposal for Precision Autism https://www.biorxiv.org/content/10.1101/2021.07.28.454081v1.full

More Elizabeth Barbara Torres's questions See All
Similar questions and discussions